Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Terry J Smith

Showing results (21-30 of 232) with videos related to

Pageof 24
Sort By:
Expert Opinion on Drug Safety|June 15, 2026
Safety profile of teprotumumab-trbw, the first and only medicine approved by the FDA for the treatment of thyroid eye diseaseTerry J Smith
The Lancet. Diabetes & Endocrinology|August 14, 2025
Thyroid eye disease and the IGF-1 receptorTerry J Smith
Eye (London, England)|November 3, 2018
The insulin-like growth factor-I receptor and its role in thyroid-associated ophthalmopathyTerry J Smith
The Journal of Clinical Endocrinology and Metabolism|May 8, 2014
Advances in understanding autoimmune pituitary disease: standardized methods for autoantibody detectionTerry J Smith
Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society|February 11, 2020
Teprotumumab in Thyroid-Associated Ophthalmopathy: Rationale for Therapeutic Insulin-Like Growth Factor-I Receptor InhibitionTerry J Smith
European Thyroid Journal|January 29, 2021
Teprotumumab Treatment for Thyroid-Associated OphthalmopathyTerry J Smith
The Journal of Clinical Endocrinology and Metabolism|September 24, 2020
Slit2 Regulates Hyaluronan & Cytokine Synthesis in Fibrocytes: Potential Relevance to Thyroid-Associated OphthalmopathyRoshini Fernando, Terry J Smith
European Journal of Endocrinology|August 2, 2019
Will biological agents supplant systemic glucocorticoids as the first-line treatment for thyroid-associated ophthalmopathy?Terry J Smith, Luigi Bartalena
Endocrinology|October 8, 2005
T helper type 1 and type 2 cytokines exert divergent influence on the induction of prostaglandin E2 and hyaluronan synthesis by interleukin-1beta in orbital fibroblasts: implications for the pathogenesis of thyroid-associated ophthalmopathyRui Han, Terry J Smith
International Journal of Molecular Sciences|July 2, 2021
3' <i>Tth</i> Endonuclease Cleavage Polymerase Chain Reaction (3TEC-PCR) Technology for Single-Base-Specific Multiplex Pathogen Detection using a Two-Oligonucleotide SystemOwen Higgins, Terry J Smith
Pageof 24

Showing results (21-30 of 232) with videos related to

Sort By:
Pageof 24
Expert Opinion on Drug Safety|June 15, 2026
Safety profile of teprotumumab-trbw, the first and only medicine approved by the FDA for the treatment of thyroid eye diseaseTerry J Smith
The Lancet. Diabetes & Endocrinology|August 14, 2025
Thyroid eye disease and the IGF-1 receptorTerry J Smith
Eye (London, England)|November 3, 2018
The insulin-like growth factor-I receptor and its role in thyroid-associated ophthalmopathyTerry J Smith
The Journal of Clinical Endocrinology and Metabolism|May 8, 2014
Advances in understanding autoimmune pituitary disease: standardized methods for autoantibody detectionTerry J Smith
Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society|February 11, 2020
Teprotumumab in Thyroid-Associated Ophthalmopathy: Rationale for Therapeutic Insulin-Like Growth Factor-I Receptor InhibitionTerry J Smith
European Thyroid Journal|January 29, 2021
Teprotumumab Treatment for Thyroid-Associated OphthalmopathyTerry J Smith
The Journal of Clinical Endocrinology and Metabolism|September 24, 2020
Slit2 Regulates Hyaluronan & Cytokine Synthesis in Fibrocytes: Potential Relevance to Thyroid-Associated OphthalmopathyRoshini Fernando, Terry J Smith
European Journal of Endocrinology|August 2, 2019
Will biological agents supplant systemic glucocorticoids as the first-line treatment for thyroid-associated ophthalmopathy?Terry J Smith, Luigi Bartalena
Endocrinology|October 8, 2005
T helper type 1 and type 2 cytokines exert divergent influence on the induction of prostaglandin E2 and hyaluronan synthesis by interleukin-1beta in orbital fibroblasts: implications for the pathogenesis of thyroid-associated ophthalmopathyRui Han, Terry J Smith
International Journal of Molecular Sciences|July 2, 2021
3' <i>Tth</i> Endonuclease Cleavage Polymerase Chain Reaction (3TEC-PCR) Technology for Single-Base-Specific Multiplex Pathogen Detection using a Two-Oligonucleotide SystemOwen Higgins, Terry J Smith
Pageof 24